Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 17/20 | 0.59 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.46 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6995800 | 0.92 | EGFR (0.68) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8315593 | 0.89 | EGFR (0.59) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8485063 | 0.89 | EGFR (0.57) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL6991387 | 0.86 | EGFR (0.77) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL6995186 | 0.86 | EGFR (0.58) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8488608 | 0.85 | EGFR (0.58) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8522097 | 0.84 | EGFR (0.59) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8317606 | 0.83 | EGFR (0.72) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8486998 | 0.82 | EGFR (0.54) | EGFRERBB2HPGDHTTMAPT | |
| SCHEMBL8314697 | 0.82 | EGFR (0.68) | EGFRERBB2HPGDHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977102-A | INHIBITORY EFFECT ON SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES OR EPIDERMAL GROWTH FACTOR; ANTITUMOR,-CARCINOGENIC, -METASTASIS,-PROLIFERATION AGENTS AND -INFLAMMATORY AGENTS; PSORIASIS; ANGIOGENESIS INHIBITORS; IMMUNOLOGY; | DR. KARL THOMAE GMBH (DE) | 1999-11-02 | — | — | US | disclosed |
| EP-0885227-A1 | PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | Dr. Karl Thomae GmbH (DE) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997032882-A1 | PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | DR. KARL THOMAE GMBH (DE) | 1997-09-12 | — | — | WO | disclosed |